Literature DB >> 32379

A method to estimate binding constants at variable protein concentrations.

J Romer, M H Bickel.   

Abstract

The association constants of the binding of chlorpromazine and imipramine to serum albumin at low saturation of the protein were determined by a new experimental approach with the protein concentration rather than the ligand concentration being varied. This approach is suitable for estimating binding constants in systems with one class of binding sites. In addition, the method is proposed to complement conventional binding studies of systems with two classes of binding constant with higher accuracy.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 32379     DOI: 10.1111/j.2042-7158.1979.tb13411.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  6 in total

1.  Interaction of potassium mono and di phosphates with bovine serum albumin studied by fluorescence quenching method.

Authors:  S Bakkialakshmi; B Shanthi; D Chandrakala
Journal:  J Fluoresc       Date:  2010-11-12       Impact factor: 2.217

2.  Prazosin protein binding in health and disease.

Authors:  P Rubin; T Blaschke
Journal:  Br J Clin Pharmacol       Date:  1980-02       Impact factor: 4.335

3.  Spectrofluorimetric study of the interaction of methyl-parathion with fish serum albumin.

Authors:  Dilson Silva; Madelayne Cortez-Moreira; Vera Lúcia Freire Cunha Bastos; Jayme Cunha Bastos; Célia Martins Cortez
Journal:  Fish Physiol Biochem       Date:  2009-03-18       Impact factor: 2.794

4.  Plasma protein binding of penbutolol in pregnancy.

Authors:  C Aquirre; J M Rodriguez-Sasiain; P Navajas; R Calvo
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Jan-Mar       Impact factor: 2.441

5.  Brain Distribution of Drugs: Pharmacokinetic Considerations.

Authors:  Irena Loryan; Margareta Hammarlund-Udenaes; Stina Syvänen
Journal:  Handb Exp Pharmacol       Date:  2022

6.  Unbound Brain-to-Plasma Partition Coefficient, Kp,uu,brain-a Game Changing Parameter for CNS Drug Discovery and Development.

Authors:  Irena Loryan; Andreas Reichel; Bo Feng; Christoffer Bundgaard; Christopher Shaffer; Cory Kalvass; Dallas Bednarczyk; Denise Morrison; Dominique Lesuisse; Edmund Hoppe; Georg C Terstappen; Holger Fischer; Li Di; Nicola Colclough; Scott Summerfield; Stephen T Buckley; Tristan S Maurer; Markus Fridén
Journal:  Pharm Res       Date:  2022-04-11       Impact factor: 4.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.